SCHEMBL114870

SCHEMBL114870

O=C(O)[C@H]1NCC[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1364961 1.00
SCHEMBL1256601 1.00
SCHEMBL178592 1.00
SCHEMBL63812 1.00
SCHEMBL7412 1.00
SCHEMBL2025245 1.00
SCHEMBL8088 1.00
SCHEMBL200242 1.00
Hydrochloric Acid SCHEMBL23391535 0.98 SLC1A2 (0.58)
Methane SCHEMBL14937659 0.98 SLC1A2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250290049-A1 BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS CODEXIS INC (US) 2025-09-18 US claimed
WO-2025124444-A1 USE OF HYDROXYPROLINE AND DERIVATIVE THEREOF, BIOLOGICAL HERBICIDE, BROAD-SPECTRUM HERBICIDE, AND WEED CONTROL METHOD 三亚市国家耐盐碱水稻技术创新中心 2025-06-19 WO claimed
CN-120130489-A Application of hydroxyproline and derivatives thereof, biological herbicide, broad-spectrum herbicide and weed control method 三亚市国家耐盐碱水稻技术创新中心 2025-06-13 CN claimed
US-20250170216-A1 CONJUGATED HEPCIDIN MIMETICS PROTAGONIST THERAPEUTICS, INC. 2025-05-29 US claimed
CN-116514864-B Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid 南京优氟医药科技有限公司 2025-05-23 CN claimed
US-20250003979-A1 METABOLOMIC PROFILES FOR PREDICTION OF FUNCTIONAL NEUROLOGICAL OUTCOME OR DEATH FOLLOWING SEVERE TRAUMATIC BRAIN INJURY THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2025-01-02 US claimed
EP-4472996-A2 CONJUGATED HEPCIDIN MIMETICS Protagonist Therapeutics, Inc. (US) 2024-12-11 EP claimed
EP-4367514-A1 METABOLOMIC PROFILES FOR PREDICTION OF FUNCTIONAL NEUROLOGICAL OUTCOME OR DEATH FOLLOWING SEVERE TRAUMATIC BRAIN INJURY UTI Limited Partnership (CA) 2024-05-15 EP claimed
CN-114163371-B Meropenem side chain optical isomer, preparation method and application thereof, and meropenem side chain impurity detection method 天津市敬业精细化工有限公司 2024-05-14 CN claimed
US-20230303647-A1 CYCLIC CHEMERIN-9 DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2023-09-28 US claimed
EP-1166767-A2 Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-01-02 EP claimed
EP-1159952-A1 COSMETICS KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-12-05 EP claimed
EP-0542222-B1 Process for producing trans-L-hydroxyproline KYOWA HAKKO KOGYO KK (JP) 1997-06-11 EP claimed
US-5364775-A Biosynthesis from collagen by decomposing other amino acids KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-11-15 US claimed
EP-0542222-A2 Process for producing trans-L-hydroxyproline KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-05-19 EP claimed
EP-0307390-A2 Chemical compound consisting of cis-3-hydroxyproline for therapeutic treatment, and process for its preparation MERCKLE GMBH (DE) 1989-03-15 EP claimed
EP-0084826-B1 ANTIBIOTIC COMPOUND Bristol-Myers Company (US) 1986-11-05 EP claimed
US-4533631-A Fermentation process for preparation of antibiotic Bu-2517 BRISTOL-MYERS COMPANY (US) 1985-08-06 US claimed
US-4409210-A PEPTIDE ANTIBIOTICS BU-2517 BRISTOL-MYERS COMPANY (US) 1983-10-11 US claimed
EP-0084826-A2 Antibiotic compound Bristol-Myers Company (US) 1983-08-03 EP claimed